PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Return
55.85%
This Quarter Return
+20.52%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$10.8B
AUM Growth
+$1.43B
(+15%)
Cap. Flow
-$149M
Cap. Flow
% of AUM
-1.38%
Top 10 Holdings %
Top 10 Hldgs %
22.86%
Holding
298
New
45
Increased
79
Reduced
106
Closed
31
Top Buys
| 1 |
Merck
MRK
|
$77.6M |
| 2 |
Synopsys
SNPS
|
$73.5M |
| 3 |
Global Payments
GPN
|
$62.9M |
| 4 |
Teleflex
TFX
|
$58.9M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$51.4M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$167M |
| 2 |
UnitedHealth
UNH
|
$122M |
| 3 |
Medtronic
MDT
|
$91.6M |
| 4 |
Humana
HUM
|
$52M |
| 5 |
LOXO
Loxo Oncology, Inc
LOXO
|
$50M |
Sector Composition
| 1 | Technology | 26.76% |
| 2 | Financials | 21.8% |
| 3 | Healthcare | 19.87% |
| 4 | Communication Services | 8.39% |
| 5 | Consumer Discretionary | 7.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DESP
226
DELISTED
Despegar.com
DESP
| $1.69M | 0.02% |
113,097
| – | – |
|
|
OBSV
227
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $1.16M | 0.01% |
90,290
-84,710
| -48% | -$1.08M |
|
|
IMMP
228
Immutep
IMMP
$242M
| $1.09M | 0.01% |
500,000
| – | – |
|
229
Lyft
LYFT
$6.91B
| $979K | 0.01% |
+12,500
| New | +$979K |
|
|
VNET
230
VNET Group
VNET
$2.13B
| $918K | 0.01% |
115,674
+45,007
| +64% | +$357K |
|
231
Fate Therapeutics
FATE
$116M
| $778K | 0.01% |
+44,300
| New | +$778K |
|
232
NetEase
NTES
$85B
| $736K | 0.01% |
15,240
+2,270
| +18% | +$110K |
|
|
JOBS
233
DELISTED
51job, Inc.
JOBS
| $689K | 0.01% |
8,850
-2,722
| -24% | -$212K |
|
|
VRNA
234
Verona Pharma
VRNA
$9.2B
| $650K | 0.01% |
100,000
| – | – |
|
235
Summit Therapeutics
SMMT
$19.3B
| $641K | 0.01% |
350,000
| – | – |
|
236
Shopify
SHOP
$191B
| $620K | 0.01% |
+30,000
| New | +$620K |
|
|
VIVE
237
DELISTED
VIVEVE MED INC
VIVE
| $566K | 0.01% |
603
-109
| -15% | -$102K |
|
238
NovaGold Resources
NG
$2.75B
| $529K | ﹤0.01% |
126,946
| – | – |
|
|
NBIS
239
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.6B
| $481K | ﹤0.01% |
+14,016
| New | +$481K |
|
|
FENG
240
Phoenix New Media
FENG
$27.7M
| $440K | ﹤0.01% |
17,426
-14,060
| -45% | -$355K |
|
241
Esquire Financial Holdings
ESQ
$828M
| $401K | ﹤0.01% |
17,638
-12,447
| -41% | -$283K |
|
242
Texas Capital Bancshares
TCBI
$3.96B
| $347K | ﹤0.01% |
6,360
+295
| +5% | +$16.1K |
|
243
Goldman Sachs
GS
$223B
| $249K | ﹤0.01% |
1,298
-339
| -21% | -$65K |
|
244
Amgen
AMGN
$153B
| – | – |
-101,075
| Closed | -$19.7M |
|
245
Amphenol
APH
$135B
| – | – |
-94,588
| Closed | -$1.92M |
|
246
Biogen
BIIB
$20.6B
| – | – |
-50,000
| Closed | -$15M |
|
247
CVS Health
CVS
$93.6B
| – | – |
-275,000
| Closed | -$18M |
|
248
Quest Diagnostics
DGX
$20.5B
| – | – |
-149,254
| Closed | -$12.4M |
|
249
Gilead Sciences
GILD
$143B
| – | – |
-225,000
| Closed | -$14.1M |
|
|
250
Humana
HUM
$37B
| – | – |
-181,637
| Closed | -$52M |
|